Patents by Inventor Hee Sook Lee

Hee Sook Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 4-carbonylamino-4-phenylpyrimidine compound or pharmaceutically acceptable salt thereof
    Patent number: 12208098
    Abstract: The present invention relates to a novel 4-carbonylamino-4-phenylpyrimidine compound or a pharmaceutically acceptable salt thereof. Specifically, the present invention relates to a novel 4-carbonylamino-4-phenylpyrimidine compound or a pharmaceutically acceptable salt thereof, which exhibits GDH activity and as such, is effective for prevention or treatment of obesity, diabetes, or fatty liver.
    Type: Grant
    Filed: November 26, 2018
    Date of Patent: January 28, 2025
    Assignees: Gachon University Of Industry-Academic Cooperation Foundation, Gil Medical Center
    Inventors: Dongyun Shin, Cheol Soo Choi, Hee-Sook Jun, Cheol Soon Lee, Seung-Yong Seo, Hojung Choi, Sung Jean Park, Onnuri Bae, Hyunhee Oh, Shi-Young Park
  • Use of a novel aminopyridine derivative to prevent or treat cancer
    Patent number: 9206132
    Abstract: An aminopyridine derivative of Formula 1 and a method of preventing or treating cancer using the same. Formula 1: In Formula 1: X1 and X2 are each independently selected from the group consisting of carbon and nitrogen; R1 to R5 are each independently selected from the group consisting of a hydrogen, a straight, a branched, or cyclo alkyl of C1-C4, a halogen, and a hydroxyl; and R6 is a hydrogen or an alkyl of C1-C6.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: December 8, 2015
    Assignee: Medicinal Bioconvergence Research Center
    Inventors: Sunghoon Kim, Hee Sook Lee, Young Sun Oh, Dae Gyu Kim
  • USE OF A NOVEL AMINOPYRIDINE DERIVATIVE TO PREVENT OR TREAT CANCER
    Publication number: 20150038531
    Abstract: An aminopyridine derivative of Formula 1 and a method of preventing or treating cancer using the same. Formula 1: In Formula 1: X1 and X2 are each independently selected from the group consisting of carbon and nitrogen; R1 to R5 are each independently selected from the group consisting of a hydrogen, a straight, a branched, or cyclo alkyl of C1-C4, a halogen, and a hydroxyl; and R6 is a hydrogen or an alkyl of C1-C6.
    Type: Application
    Filed: October 20, 2014
    Publication date: February 5, 2015
    Inventors: Sunghoon Kim, Hee Sook Lee, Young Sun Oh, Dae Gyu Kim
  • NOVEL ANILINE DERIVATIVES AND USE THEREOF
    Publication number: 20140142333
    Abstract: Aniline derivatives for anticancer treatment including a compound of the Formula 1, or a derivative thereof, as an active ingredient,
    Type: Application
    Filed: February 4, 2014
    Publication date: May 22, 2014
    Applicant: NEOMICS Co, Ltd.
    Inventors: Sunghoon KIM, Hee Sook Lee, Young Sun Oh, Dae Gyu Kim
  • CONTAINER LID WITH A RFID TAG
    Publication number: 20100102967
    Abstract: The present invention provides a container lid with a removable built-in RFID tag which makes it easy to perform general management, such as information management, inventory management, use list management, hazardous material management, etc., of contents stored in the container. The container lid with the RFID tag according to the present invention includes a main body which covers an open end of a container, and a tag mount which protrudes from the upper surface of the main body. The tag mount is open on the upper end thereof and has therein an installation space, into which the RFID tag is inserted through the open upper end of the tag mount. The container lid further includes a tag holder which holds and supports the RFID tag in the tag mount, and a tag mount cover which covers the open upper end of the tag mount.
    Type: Application
    Filed: December 9, 2008
    Publication date: April 29, 2010
    Inventors: Sang Mok Lee, Hee Sook Lee, Woo Seong Kim, Dae Hyun Cho, Sun Hee Lee, Sang Yeul Lee